Table 1. Relationship between TAB3 expression and clinicopathological features in 162 CRC patients.
Parameters | Case | TAB3 expression | P value | |
---|---|---|---|---|
162 | Low | High | ||
Age (years) | ||||
<60 | 102 | 51 | 51 | 0.255 |
≥60 | 60 | 24 | 36 | |
Gender | ||||
Female | 77 | 40 | 37 | 0.207 |
Male | 85 | 35 | 50 | |
Tumor size (cm) | ||||
<5 | 88 | 46 | 42 | 0.115 |
≥5 | 74 | 29 | 45 | |
Histological type | ||||
Differentiated | 130 | 65 | 65 | 0.075 |
Undifferentiated | 32 | 10 | 22 | |
Lymphatic metastasis | ||||
Negative | 91 | 58 | 33 | <0.001** |
Positive | 71 | 17 | 54 | |
Venous invasion | ||||
Negative | 116 | 60 | 56 | 0.036* |
Positive | 46 | 15 | 31 | |
TNM staging | ||||
I/II | 97 | 55 | 42 | 0.001** |
III/IV | 65 | 20 | 45 |
P value was generated by comparing all subgroups and analyzed by the chi-square test. P < 0.05 was considered as statistically significant.